Hello Shimon,
The questions largely depend on the type of device, type of sterilisation performed, and the sterilisation validation process. As you mention EtO (or EO) residuals, then assuming you are discussing Ethylene Oxide sterilisation. For EtO residuals, this is usually performed during the sterilisation validation process because testing routinely during lot release would be time and cost prohibitive to companies. However, depending on the product, i.e. a dense product, this might be part of the lot release. Biological Indicators (BI) are tested for each sterilisation load, not necessarily a lot of product, because the sterilisation validation process accepts the use of BIs as the load release mechanism since testing sterility each and every time is reason validation is performed. Bioburden and LAL testing also depend heavily on type of product, environmental monitoring, sterilisation validation, etc. There are a number of standards which do explain this further such as ISO 10993-7, ISO 11135 for EtO, ISO 14644 series, ISO 11737 series, etc.
------------------------------
Richard Vincins RAC
Vice President Global Regulatory Affairs
------------------------------
Original Message:
Sent: 14-Jul-2021 09:01
From: Shimon Vaknin
Subject: Frequency and sample size for LOT release of EtO sterilized products
Hi fellows,
I was given to understand that EtO residuals and biological indicators are tested for each lot. 1 unit for residuals and biological indicators as defined in the process.
The periodic tests are bio-burden and LAL, and they are usually done every quarter or after a certain number of manufactured LOTs. The sample size varies... I guess 5-10 units.
What is your experience with that, and is there a clear guidance regarding frequency and sample size for these types of tests?
Thanks,
Shimon